Hofmeister Robert 4
4 · TCR2 THERAPEUTICS INC. · Filed Apr 12, 2019
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-04-11+127,512→ 127,512 totalExercise: $16.11Exp: 2029-04-10→ Common Stock (127,512 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.